PATENT CLAIM ANALYSIS

Application Number: 16405588
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["435", "007100"]

Abstract:
Provided herein are multiplex assays for detecting antibodies indicative of presence and stage of syphilis infection in an individual. Individuals infected with syphilis produce antibodies directed to syphilis components and the lipid cellular debris associated with the infection. The present disclosure represents the first combination of these diverse antibody targets in a single assay.

Claim (Index 6):
The method of  claim 2 , wherein step (c) comprises contacting the sample-bead mixture with a first labeled, anti-human Ig antibody specific for IgG and a second labeled, anti-human Ig antibody specific for IgM.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 100.0
- Lexical Diversity: 1.29545
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15701272', '14079634', '14329236', '13421681', '13429183']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6811970556992155
- 35 USC 102 Novelty (BERT): 0.5876681589514657
- Combined Prediction Score: 0.6718441660244405
- Mean Citation Score: 362.17091
- Max Citation Score: 487.21292
- Similarity Product: 464.9580277682328

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test